Abstract
Objective: To compare the effectiveness of intravenous (IV) diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation (AF).
Methods: This prospective, randomised study was conducted in the Emergency Department of the Uludag University Medical Faculty Hospital, Bursa, Turkey. Forty AF patients with a ventricular rate ⩾120/minute and systolic blood pressure ⩾95 mm Hg were included and randomised to receive IV diltiazem 0.25 mg/kg (maximum 25 mg) or metoprolol 0.15 mg/kg (maximum 10 mg) over 2 minutes. Blood pressures and heart rate were measured at 2, 5, 10, 15, and 20 minutes. Successful treatment was defined as fall in ventricular rate to below 100/minute or decrease in ventricular rate by 20% or return to sinus rhythm.
Results: Between January 2000 and July 2002, 40 patients (18 men, 22 women) met the inclusion criteria. Of these 20 (8 men, 12 women; mean age 60.2 years, range 31–82) received diltiazem and 20 (10 men, 10 women; mean age 64.0 years, range 31–82) received metoprolol. The success rate at 20 minutes for diltiazem and metoprolol was 90% (n = 18) and 80% (n = 16), respectively. The success rate at 2 minutes was higher in the diltiazem group. The percentage decrease in ventricular rate was higher in the diltiazem group at each time interval. None of the patients had hypotension.
Conclusion: Both diltiazem and metoprolol were safe and effective for the management of rapid ventricular rate in AF. However, the rate control effect began earlier and the percentage decrease in ventricular rate was higher with diltiazem than with metoprolol.
Full Text
The Full Text of this article is available as a PDF (71.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amsterdam E. A., Kulcyski J., Ridgeway M. G. Efficacy of cardioselective beta-adrenergic blockade with intravenously administered metoprolol in the treatment of supraventricular tachyarrhythmias. J Clin Pharmacol. 1991 Aug;31(8):714–718. doi: 10.1002/j.1552-4604.1991.tb03765.x. [DOI] [PubMed] [Google Scholar]
- Dias V. C., Weir S. J., Ellenbogen K. A. Pharmacokinetics and pharmacodynamics of intravenous diltiazem in patients with atrial fibrillation or atrial flutter. Circulation. 1992 Nov;86(5):1421–1428. doi: 10.1161/01.cir.86.5.1421. [DOI] [PubMed] [Google Scholar]
- Feinberg W. M., Blackshear J. L., Laupacis A., Kronmal R., Hart R. G. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995 Mar 13;155(5):469–473. [PubMed] [Google Scholar]
- Goldenberg I. F., Lewis W. R., Dias V. C., Heywood J. T., Pedersen W. R. Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure. Am J Cardiol. 1994 Nov 1;74(9):884–889. doi: 10.1016/0002-9149(94)90580-0. [DOI] [PubMed] [Google Scholar]
- Hagens Vincent E., Van Gelder Isabelle C., Crijns Harry J. G. M., RAte Control Versus Electrical Cardioversion Of Persistent Atrial Fibrillation (RACE) Study Group The RACE study in perspective of randomized studies on management of persistent atrial fibrillation. Card Electrophysiol Rev. 2003 Jun;7(2):118–121. doi: 10.1023/a:1027439430017. [DOI] [PubMed] [Google Scholar]
- Hazard P. B., Burnett C. R. Treatment of multifocal atrial tachycardia with metoprolol. Crit Care Med. 1987 Jan;15(1):20–25. doi: 10.1097/00003246-198701000-00004. [DOI] [PubMed] [Google Scholar]
- Kannel W. B., Abbott R. D., Savage D. D., McNamara P. M. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982 Apr 29;306(17):1018–1022. doi: 10.1056/NEJM198204293061703. [DOI] [PubMed] [Google Scholar]
- Phillips B. G., Gandhi A. J., Sanoski C. A., Just V. L., Bauman J. L. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter. Pharmacotherapy. 1997 Nov-Dec;17(6):1238–1245. [PubMed] [Google Scholar]
- Pritchett E. L. Management of atrial fibrillation. N Engl J Med. 1992 May 7;326(19):1264–1271. doi: 10.1056/NEJM199205073261906. [DOI] [PubMed] [Google Scholar]
- Rizos I., Senges J., Jauernig R., Lengfelder W., Czygan E., Brachmann J., Kübler W. Differential effects of sotalol and metoprolol on induction of paroxysmal supraventricular tachycardia. Am J Cardiol. 1984 Apr 1;53(8):1022–1027. doi: 10.1016/0002-9149(84)90630-1. [DOI] [PubMed] [Google Scholar]
- Schreck D. M., Rivera A. R., Tricarico V. J. Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin. Ann Emerg Med. 1997 Jan;29(1):135–140. doi: 10.1016/s0196-0644(97)70319-6. [DOI] [PubMed] [Google Scholar]
- Shettigar U. R. Management of rapid ventricular rate in acute atrial fibrillation. Int J Clin Pharmacol Ther. 1994 May;32(5):240–245. [PubMed] [Google Scholar]
- Wang H. E., O'connor R. E., Megargel R. E., Schnyder M. E., Morrison D. M., Barnes T. A., Fitzkee A. The use of diltiazem for treating rapid atrial fibrillation in the out-of-hospital setting. Ann Emerg Med. 2001 Jan;37(1):38–45. doi: 10.1067/mem.2001.111518. [DOI] [PubMed] [Google Scholar]
- Wolf P. A., Abbott R. D., Kannel W. B. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med. 1987 Sep;147(9):1561–1564. [PubMed] [Google Scholar]
- Wyse D. G., Waldo A. L., DiMarco J. P., Domanski M. J., Rosenberg Y., Schron E. B., Kellen J. C., Greene H. L., Mickel M. C., Dalquist J. E. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002 Dec 5;347(23):1825–1833. doi: 10.1056/NEJMoa021328. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.